Related Experiment Video
Updated: May 26, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
HPV vaccine implementation in STD clinics--STD Surveillance Network
Elissa Meites1, Eloisa Llata, Susan Hariri
1Division of STD Prevention, CDC, Atlanta, GA 30333, USA. emeites@cdc.gov
Abstract:
We surveyed selected public sexually transmitted disease clinics in the United States regarding human papillomavirus vaccine availability, target populations, funding sources, and barriers. Although nearly all had experience offering other vaccines, only 7 of 42 clinics (17%) offered human papillomavirus vaccine. Vaccine cost, staff time, and follow-up issues were commonly reported barriers.
Related Concept Videos
Sexually Transmitted Infections
Principles of Disease Surveillance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
